Top companies developing medicines for children in developing countries 2014

Number of medicines for children being developed by pharmaceutical companies in developing countries as of 2014

by Statista Research Department, last edited Nov 21, 2014
Top companies developing medicines for children in developing countries 2014 This statistic displays the number of products being developed for children in developing countries by pharmaceutical companies as of 2014. At this time, Bristol-Myers Squibb had 2 products in development for children.
Show more

Number of medicines for children being developed by pharmaceutical companies in developing countries as of 2014

You need to log in to download this statistic
Register for free
Already a member?
Log in
Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Statista is a great source of knowledge, and pretty helpful to manage the daily work.
Christof Baron

Christof Baron
CEO, MindShare Germany

Statistics on "Pharmaceutical market in Italy"
  • Market overview
The most important statistics
  • Pharmacy figures
  • Pharmaceutical expenditure
  • Pharmaceutical consumption
  • Brand name and generic drugs
  • Nonprescription drugs
  • Health supplements
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.